Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - Mature results for medically inoperable patients

Lung Cancer

Volumn 51, Issue 1, 2006, Pages 97-103

  Nyman, Jan ^a   Johansson, Karl Axel ^a   Hultén, Ulla ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body frame; Hypofractionation; Medically inoperable; NSCLC; Stage I; Stereotactic radiotherapy; Survival

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ATELECTASIS; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFECTION; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RIB FRACTURE; SEX DIFFERENCE; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; THORAX PAIN; TOXICITY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 30644467278     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.08.011     Document Type: Article

References (23)

1. X. Qiao, O. Tullgren, I. Lax, F. Sirzén, and R. Lewensohn The role of radiotherapy of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
2. P.A. Kupelian, R. Komaki, and P. Allen Prognostic factors in the treatment of node-negative non-small cell lung carcinoma with radiotherapy alone Int J Radiat Oncol Biol Phys 36 1996 607 613
3. H. Blomgren, I. Lax, I. Näslund, and R. Svanström Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients Acta Oncol 34 1995 861 870
4. H. Onishi, T. Araki, H. Shiato, Y. Nagata, M. Hiraoka, and K. Gomi Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung cancer. Clinical outcomes in 245 subjects in Japanese multiinstitutional study Cancer 101 2004 1623 1631
5. R. Timmerman, L. Papiez, R. McGarry, L. Likes, C. DesRosiers, and S. Frost Extracranial stereotactic radioablation. Results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955
6. I. Lax, H. Blomgren, I. Näslund, and R. Svanström Stereotactic radiotherapy of malignancies in the abdomen Acta Oncol 33 1994 677 683
7. Saunders M, Dische S, Barret A, Harvey A, Griffiths G, Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicenter trial. CHART steering committee.
8. I. Lax, H. Blomgren, D. Larsson, and I. Näslund Extracranial stereotactic radiosurgery of localized targets J Radiosurgery 1 1998 135 148
9. S. Lee, E. Choi, H. Park, S. Ahn, J. Kim, and K. Kim Stereotactic body framed based fractionated radiosurgery on consecutive days for primary or metastatic tumors of the lung Lung Cancer 40 2003 309 315
10. J. Wulf, U. Haedinger, U. Oppitz, W. Thiele, G. Mueller, and M. Flentje Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients Int J Radiat Oncol Biol Phys 60 2004 186 196
11. H. Hof, K. Herfarth, M. Münter, A. Hoess, J. Motsch, and M. Wannenmacher Stereotactic single-dose radiotherapy of stage I non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 56 2003 335 341
12. J. Fowler The first James Kirk memorial lecture. What next in fractionation of radiotherapy? Br J Cancer 6 1984 285 300
13. M. Uematsu, A. Shioda, A. Suda, T. Fukui, Y. Ozeki, and Y. Hama Computed tomogagraphy-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5-year experience Int J Radiat Oncol Biol Phys 51 2001 666 670
14. Y. Nagata, Y. Negoro, T. Aoki, T. Mizowaki, K. Takayama, and M. Kokubo Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame Int J Radiat Oncol Biol Phys 52 2002 1041 1046
15. S. Fukumoto, H. Shirato, S. Shimizu, S. Ogura, R. Onimaru, and K. Kitamura Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas Cancer 95 2002 1546 1553
16. H. Blomgren, I. Lax, H. Göransson, T. Kraepelien, B. Nilsson, and I. Näslund Radiosurgery for tumors in the body: clinical experience using a new method J Radiosurgery 1 1998 63 74
17. R. Whyte, R. Crownover, M. Murphy, D. Martin, T. Rice, and M. DeCamp Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial Ann Thorac Surg 75 2003 1097 1101
18. R. Hara, J. Itami, T. Kondo, T. Aruga, Y. Abe, and M. Ito Stereotactic single high dose irradiation of lung tumors under respiratory gating Radiother Oncol 63 2002 159 163
19. M. Mac Manus, and R. Hicks PET scanning in lung cancer: current status and future directions Semin Surg Oncol 21 2003 149 155
20. R. Arriagada, B. Bergman, A. Dunant, T. LeChevalier, J.P. Pignon, and J. Vansteenkiste Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
21. T. Winton, R. Livingstone, D. Johnson, J. Rigas, M. Johnston, and C. Butts A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR. 10 J Clin Oncol 22 2004 7018
22. G. Strauss, J. Herndon, and M. Maddaus Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of cancer and leukaemia group B (CALGB) Protocol 9633 J Clin Oncol 22 2004 7019
23. G. Scagliotti, R. Fossati, V. Torri, L. Crinò, G. Giaccone, and G. Silvano Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIa non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453 1461